Results 121 to 130 of about 257,683 (336)

Unveiling the complexity of cellular senescence in cancers: From mechanism to therapeutic opportunities

open access: yesBMEMat, EarlyView.
This review highlights the complex roles of cellular senescence in cancer progression and suppression, discusses the mechanisms and regulatory pathways involved, and evaluates the efficacy of the “One‐Two punch” sequential treatment approach while addressing emerging challenges in this novel therapeutic strategy.
Qiuming Pan   +12 more
wiley   +1 more source

Extranodal diffuse large B‐cell lymphoma: Clinical and molecular insights with survival outcomes from the multicenter EXPECT study

open access: yesCancer Communications, EarlyView.
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of aggressive non‐Hodgkin's lymphoma with distinct clinical and molecular heterogeneity. DLBCL that arises in extranodal organs is particularly linked to poor prognosis. This study aimed to determine the clinical and molecular characteristics of extranodal involvement (
Si‐Yuan Chen   +46 more
wiley   +1 more source

Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide) [PDF]

open access: bronze, 1960
Peter R. Coggins   +2 more
openalex   +1 more source

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide versus anthracycline plus docetaxel and cyclophosphamide regimen in women with high‐risk, HER2‐negative breast cancer: An open‐label, randomized controlled trial

open access: yesCancer Communications, EarlyView.
Abstract Background The standard adjuvant chemotherapy for early‐stage, high‐risk breast cancer includes anthracyclines and taxanes. While anthracycline‐based regimens have proven effective in human epidermal growth factor receptor 2 (HER2)‐positive breast cancer, their efficacy may be reduced in HER2‐negative patients due to the lack of co ...
Yu Song   +6 more
wiley   +1 more source

The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide

open access: yesScience, 2013
S. Viaud   +32 more
semanticscholar   +1 more source

Cyclophosphamide efficacy inmaintenance therapy of nephrotic syndrome in patients withchronic glomerulonephritis

open access: yesТерапевтический архив, 2004
Mm. To study effects of cyclophosphamide (CP) on duration of remission in chronic glomerulonephritis (CGN) with nephrotic syndrome (NS). Material and methods.
V L Duman, L I Shkerina
doaj  

Cyclophosphamide in Hodgkin's Disease and Related Disorders [PDF]

open access: green, 1960
J. Q. Matthias   +2 more
openalex   +1 more source

Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer

open access: yesNew England Journal of Medicine, 1996
W. Mcguire   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy